Niacinamide for carcinoma, squamous cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Dec 2018: Trial started, NCT03769285
  2. 7 Dec 2018: Trial registered, NCT03769285

The trials

NCT03769285: Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

State
State not given
Phase
Phase 2
People
120 taking part
Started
3 Dec 2018
Primary completion
Dec 2023
Arms
Nicotinamide
Results
None posted
  1. 3 Dec 2018: Trial started
  2. 7 Dec 2018: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Nicotinamide.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.